Blievernicht Medical Associate is categorized under Health Services in Fletcher, NC and active since 2003.
Blievernicht Medical Associate was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Steve Blievernicht at the company’s single location by writing to 242 Old Concord Road, Fletcher, North Carolina NC 28732 or by phoning (828) 628-7887. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Blievernicht Medical Associate |
| Contact Person: | Steve Blievernicht |
| Address: | 242 Old Concord Road, Fletcher, North Carolina 28732 |
| Phone Number: | (828) 628-7887 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Blievernicht Medical Associate was started in 2003 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Steve Blievernicht for inquiries that concern Blievernicht Medical Associate by calling the company number (828) 628-7887, as your correspondence is most welcome. Additionally, the physical location of the single location of Blievernicht Medical Associate can be found at the coordinates 35.482966,-82.450508 as well as the street address 242 Old Concord Road in Fletcher, North Carolina 28732.
For its online presence, you may visit Blievernicht Medical Associate’s website at and engage with its social media outlets through on Twitter and on Facebook.